1
Clinical Trials associated with Regulator T Cells(Xuzhou Medical University)Safety and Efficacy of Treg Cell in the Treatment of GVHD After Allogeneic Hematopoietic Stem Cell Transplantation
This is a randomized, single-center phase 1/2a clinical trial without blinding. Regulatory T cells (Tregs) have shown potential in treating various immune-related diseases, including autoimmune disorders, transplant rejection, and inflammatory diseases. The investigators plan to recruit participants for a clinical trial to evaluate the efficacy and safety of autologous Tregs in the treatment of GVHD.
100 Clinical Results associated with Regulator T Cells(Xuzhou Medical University)
100 Translational Medicine associated with Regulator T Cells(Xuzhou Medical University)
100 Patents (Medical) associated with Regulator T Cells(Xuzhou Medical University)
100 Deals associated with Regulator T Cells(Xuzhou Medical University)